Takeshi Miyamoto

Prof. Takeshi Miyamoto

Department of Orthopedic Surgery, Keio university School of Medicine, Tokyo 160-8582, Japan

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Bone Reports
Verified
Journal Article
Open access
TMTakeshi Miyamoto
Takeshi Miyamoto
AHAkiyoshi Hirayama
Akiyoshi Hirayama
YSYuiko Sato
Yuiko Sato
TKTami Koboyashi
Tami Koboyashi
EKEri Katsuyama
Eri Katsuyama
MMMorio Matsumoto
Morio Matsumoto
Osteoporosis is a skeletal disorder characterized by compromised bone strength and increased risk of fracture. Low bone mass and/or pre-existing bone fragility fractures serve as diagnostic criteria in deciding when to start medication for osteoporosis. Although osteoporosis is a metabolic disorder, metabolic markers to predict reduced bone mass are unknown. Here, we show serum metabolomics profiles of women grouped as pre-menopausal with normal bone mineral density (BMD) (normal estrogen and normal BMD; NN), post-menopausal with normal BMD (low estrogen and normal BMD; LN) or post-menopausal with low BMD (low estrogen and low BMD; LL) using comprehensive metabolomics analysis. To do so, we enrolled healthy volunteer and osteoporosis patient female subjects, surveyed them with a questionnaire, measured their BMD, and then undertook a comprehensive metabolomics analysis of sera of the three groups named above. We identified 24 metabolites whose levels differed significantly between NN/LN and NN/LL groups, as well as 18 or 10 metabolites whose levels differed significantly between NN/LN and LN/LL, or LN/LL and NN/LN groups, respectively. Our data shows metabolomics changes represent useful markers to predict estrogen deficiency and/or bone loss.

13 May 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TMTakeshi Miyamoto
Takeshi Miyamoto
KMKei Miyakoshi
Kei Miyakoshi
YSYuiko Sato
Yuiko Sato
YKYoshifumi Kasuga
Yoshifumi Kasuga
SISatoru Ikenoue
Satoru Ikenoue
MMMorio Matsumoto
Morio Matsumoto
Calcium and nutrients are transferred from mothers to fetuses or infants during pregnancy or lactation, respectively, promoting metabolic changes in the mother, many uncharacterized. To evaluate these changes, we undertook two parallel studies. In one we analyzed fourteen clinical cases of vertebral fragility fractures, at or before three months after partum, in mothers who breastfed their infants. In the other, we enrolled 79 additional pregnant subjects, some who chose to breastfeed and others who did not, and analyzed changes in bone metabolic status starting between 34 and 36 weeks of gestation and ending one month after partum. In the larger group, bone-resorbing and bone-forming parameters such as serum TRACP5b and osteocalcin, respectively, significantly increased after partum. Among parameters that changed after partum, serum PTH and the bone-resorbing markers serum TRACP5b and urine NTX were significantly higher in mothers who only breastfed infants compared to mothers who fed infants formula or a mix of both. However, bone-forming parameters were comparable between breastfeeding and non-breast-feeding groups after partum, suggesting that elevated bone-resorption occurs only in the breastfeeding group. Radiographic analysis after partum demonstrated that no subject among the 79 analyzed showed vertebral fractures, even those who breastfed exclusively. Among fracture cases analyzed, subjects exhibited significantly lower bone mineral density than did non-fracture cases in breastfeeding-only subjects. We conclude that bone metabolic status significantly changes over the period between pregnancy and post-partum lactation, and that low bone mineral density seen in a small subset of breastfeeding-only cases likely causes post-partum vertebral fragility fractures.

22 July 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SNSatoshi Nakamura
Satoshi Nakamura
YSYuiko Sato
Yuiko Sato
TKTami Kobayashi
Tami Kobayashi
YKYosuke Kaneko
Yosuke Kaneko
EIEri Ito
Eri Ito
TMTakeshi Miyamoto
Takeshi Miyamoto
Vitamin D deficiency is a recognized risk factor for sarcopenia development, but mechanisms underlying this outcome are unclear. Here, we show that low vitamin D status worsens immobilization-induced muscle atrophy in mice. Mice globally lacking vitamin D receptor (VDR) exhibited more severe muscle atrophy following limb immobilization than controls. Moreover, immobilization-induced muscle atrophy was worse in neural crest-specific than in skeletal muscle-specific VDR-deficient mice. Tnfα expression was significantly higher in immobilized muscle of VDR-deficient relative to control mice, and was significantly elevated in neural crest-specific but not muscle-specific VDR-deficient mice. Furthermore, muscle atrophy induced by limb immobilization in low vitamin D mice was significantly inhibited in Tnfα-deficient mice. We conclude that vitamin D antagonizes immobilization-induced muscle atrophy via VDR expressed in neural crest-derived cells.

29 September 2022 in Bone
Verified
Journal Article
Closed access
RHRyosuke Hata
Ryosuke Hata
KMKana Miyamoto
Kana Miyamoto
YAYukiko Abe
Yukiko Abe
TSTakashi Sasaki
Takashi Sasaki
YOYuko Oguma
Yuko Oguma
TMTakeshi Miyamoto
Takeshi Miyamoto

8 November 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YSYuma Sakamoto
Yuma Sakamoto
TYTakuaki Yamamoto
Takuaki Yamamoto
NSNobuhiko Sugano
Nobuhiko Sugano
DTDaisuke Takahashi
Daisuke Takahashi
TWToshiyuki Watanabe
Toshiyuki Watanabe
SIShiro Ikegawa
Shiro Ikegawa
Idiopathic osteonecrosis of the femoral head (IONFH) is an ischemic disorder that causes bone necrosis of the femoral head, resulting in hip joint dysfunction. IONFH is a polygenic disease and steroid and alcohol have already known to increase its risk; however, the mechanism of IONFH remains to be elucidated. We performed a genome-wide association study using ~60,000 subjects and found two novel loci on chromosome 20q12 and 12q24. Big data analyses identified LINC01370 as a candidate susceptibility gene in the 20q12 locus. Stratified analysis by IONFH risk factors suggested that the 12q24 locus was associated with IONFH through drinking capacity. Our findings would shed new light on pathophysiology of IONFH.

10 December 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YKYosuke Kaneko
Yosuke Kaneko
NTNobuharu Tanigawa
Nobuharu Tanigawa
YSYuiko Sato
Yuiko Sato
TKTami Kobayashi
Tami Kobayashi
SNSatoshi Nakamura
Satoshi Nakamura
TMTakeshi Miyamoto
Takeshi Miyamoto
The number of osteoarthritis patients is increasing with the rise in the number of elderly people in developed countries. Osteoarthritis, which causes joint pain and deformity leading to loss of activities of daily living, is often treated surgically. Here we show that mechanical stress promotes accumulation of reactive oxygen species (ROS) in chondrocytes in vivo, resulting in chondrocyte apoptosis and leading to osteoarthritis development in a rat model. We demonstrate that mechanical stress induces ROS accumulation and inflammatory cytokine expression in cultured chondrocytes in vitro and that both are inhibited by treatment with the anti-oxidant N-acetyl cysteine (NAC). In vivo, osteoarthritis development in a rat osteoarthritis model was also significantly inhibited by oral administration of NAC. MMP13 expression and down-regulation of type II collagen in chondrocytes, both of which indicate osteoarthritis, as well as chondrocyte apoptosis in osteoarthritis rats were inhibited by NAC. Interestingly, osteoarthritis development in sham-operated control sides, likely due to disruption of normal weight-bearing activity on the control side, was also significantly inhibited by NAC. We conclude that osteoarthritis development in rats is significantly antagonized by oral NAC administration. Currently, no oral medication is available to prevent osteoarthritis development. Our work suggests that NAC may represent such a reagent and serve as osteoarthritis treatment.